[VRDN] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
13-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 13.44%
YoY- -70.06%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 86 72 1,195 208 0 695 944 -32.89%
PBT -76,689 -47,660 -28,905 -14,043 -5,494 -11,230 -9,011 42.84%
Tax 0 -135 -880 91 -48 133 362 -
NP -76,689 -47,660 -28,025 -14,043 -5,494 -11,230 -9,011 42.84%
Tax Rate - - - - - - - -
Total Cost 76,775 47,732 29,220 14,251 5,494 11,925 9,955 40.51%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -89,173.26 -66,194.44 -2,345.19 -6,751.44 0.00 -1,615.83 -954.56 112.86%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -1.15 -1.09 -0.83 -1.26 -1.48 -5.42 -4.40 -20.02%
EPS Diluted -1.15 -1.09 -0.83 -1.26 -1.48 -5.42 -4.40 -20.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.